IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+11.95%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
AUM
$366M
AUM Growth
+$366M
Cap. Flow
+$7.51M
Cap. Flow %
2.05%
Top 10 Hldgs %
50.42%
Holding
132
New
23
Increased
7
Reduced
12
Closed
26

Sector Composition

1 Healthcare 92.55%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ACRS icon
76
Aclaris Therapeutics
ACRS
$223M
$20.5K ﹤0.01%
+19,482
New +$20.5K
VTYX icon
77
Ventyx Biosciences
VTYX
$184M
$14.6K ﹤0.01%
+5,914
New +$14.6K
ASLN
78
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$6.53K ﹤0.01%
35,420
AMAM
79
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
0
PHXM
80
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
-301
Closed -$1.56K
VERV
81
DELISTED
Verve Therapeutics
VERV
0
TGTX icon
82
TG Therapeutics
TGTX
$5.03B
-32,547
Closed -$272K
SWTX
83
DELISTED
SpringWorks Therapeutics
SWTX
-178,360
Closed -$4.12M
SPY icon
84
SPDR S&P 500 ETF Trust
SPY
$656B
0
SNDX icon
85
Syndax Pharmaceuticals
SNDX
$1.39B
-4,000
Closed -$58.1K
SCPH icon
86
scPharmaceuticals
SCPH
$296M
-18,647
Closed -$133K
RVPH icon
87
Reviva Pharmaceuticals
RVPH
$31.3M
0
RVMD icon
88
Revolution Medicines
RVMD
$7.43B
0
REPL icon
89
Replimune Group
REPL
$460M
0
RCUS icon
90
Arcus Biosciences
RCUS
$1.24B
-254,876
Closed -$4.58M
RAPT icon
91
RAPT Therapeutics
RAPT
$187M
0
RARE icon
92
Ultragenyx Pharmaceutical
RARE
$3.04B
-174,945
Closed -$6.24M
QQQ icon
93
Invesco QQQ Trust
QQQ
$364B
0
PTCT icon
94
PTC Therapeutics
PTCT
$4.41B
-10,862
Closed -$243K
PRTA icon
95
Prothena Corp
PRTA
$452M
0
PCVX icon
96
Vaxcyte
PCVX
$4.17B
-142,417
Closed -$7.26M
OCUL icon
97
Ocular Therapeutix
OCUL
$2.25B
-21,590
Closed -$67.8K
NVAX icon
98
Novavax
NVAX
$1.2B
0
VTGN icon
99
VistaGen Therapeutics
VTGN
$113M
-229,100
Closed -$1.2M
XBI icon
100
SPDR S&P Biotech ETF
XBI
$5.29B
0